Cogent Biosciences, Inc.

COGT

$32.31

Name : Cogent Biosciences, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $5,606,592,000.00

EPSttm : -2.16

Cogent Biosciences, Inc.

$32.31

2.80%

$0.88

COGT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.63

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

-0.06

EPS Last/This Y

-0.05

EPS This/Next Y

1.1

Price

32.34

Target Price

55.82

Analyst Recom

1.17

Performance Q

-15.2

Upside

-364.3%

Beta

0.31

Ticker: COGT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	COGT	34.73	0.11	0.22	20166
2026-08-31	COGT	35.01	0.11	0.19	20386
2026-09-01	COGT	34.68	0.11220642102995	0.45762711864407	20647
2026-09-02	COGT	34.58	0.11	0.12	20698
2026-09-03	COGT	34.95	0.11	1.86	20779
2026-09-04	COGT	34.75	0.11	0.26	20810
2026-09-08	COGT	35.29	0.12	0.02	20850
2026-09-09	COGT	34.14	0.11	0.06	21605
2026-09-10	COGT	34.07	0.11	0.05	22222
2026-09-11	COGT	33.41	0.11	0.36	23690
2026-09-14	COGT	33.41	0.11	0.05	24333
2026-09-15	COGT	32.75	0.11	0.68	24724
2026-09-16	COGT	32.56	0.11	0.70	24972
2026-09-17	COGT	33.2	0.11	0.60	25008
2026-09-18	COGT	31.5	0.11	4.71	25069
2026-09-21	COGT	32	0.14	0.00	21505
2026-09-22	COGT	32.61	0.11	0.00	26051
2026-09-23	COGT	31.41	0.10	0.03	27357
2026-09-24	COGT	31.4	0.10	0.18	27549
2026-09-25	COGT	32.35	0.10	0.02	27822
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	COGT	34.67	-6.6	-	-2.21
2026-08-31	COGT	35.00	-6.6	-	-2.21
2026-09-01	COGT	34.68	-6.6	-	-2.21
2026-09-02	COGT	34.54	-6.6	-	-2.21
2026-09-03	COGT	34.99	-6.6	-	-2.21
2026-09-04	COGT	34.76	-6.6	-	-2.21
2026-09-08	COGT	35.28	-9.5	-	-2.21
2026-09-09	COGT	34.16	-9.5	-	-2.21
2026-09-10	COGT	34.09	-9.5	-	-2.21
2026-09-11	COGT	33.40	-9.5	-	-2.21
2026-09-14	COGT	33.40	-9.5	-	-2.21
2026-09-15	COGT	32.74	-9.5	-	-2.21
2026-09-16	COGT	32.74	-9.5	-	-2.21
2026-09-17	COGT	33.18	-9.5	-	-2.21
2026-09-18	COGT	31.49	-9.5	-	-2.21
2026-09-21	COGT	32.01	-9.5	-	-2.21
2026-09-22	COGT	32.62	-9.5	-	-2.21
2026-09-23	COGT	31.40	-9.5	-	-2.21
2026-09-24	COGT	31.41	-9.5	-	-2.21
2026-09-25	COGT	32.34	-9.5	-	-2.21
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	COGT	-27.99	4.11	11.84
2026-08-31	COGT	-27.99	4.61	11.84
2026-09-01	COGT	-28.12	4.61	11.84
2026-09-02	COGT	-28.12	4.61	11.84
2026-09-03	COGT	-28.12	4.61	11.84
2026-09-04	COGT	-28.12	4.61	11.84
2026-09-08	COGT	-28.11	4.67	11.84
2026-09-09	COGT	-28.12	4.67	11.84
2026-09-10	COGT	-28.12	4.67	11.84
2026-09-11	COGT	-28.12	4.67	12.05
2026-09-14	COGT	-28.43	4.73	12.03
2026-09-15	COGT	-28.43	4.73	12.03
2026-09-16	COGT	-28.43	4.73	12.03
2026-09-17	COGT	-28.43	4.73	12.03
2026-09-18	COGT	-28.43	4.73	12.03
2026-09-21	COGT	-28.43	4.70	12.03
2026-09-23	COGT	-28.43	4.70	12.03
2026-09-24	COGT	-28.43	4.70	12.03
2026-09-25	COGT	-28.43	4.70	11.63
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.52

Avg. EPS Est. Current Quarter

-0.55

Avg. EPS Est. Next Quarter

-0.58

Insider Transactions

-28.43

Institutional Transactions

4.7

Beta

0.31

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-76.3

Target Price

55.82

P/E

Forward P/E

PEG

P/S

P/B

11.86

P/Free Cash Flow

EPS

-2.44

Average EPS Est. Cur. Y

-2.21

EPS Next Y. (Est.)

-1.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.36

Return on Equity vs Sector %

-97.1

Return on Equity vs Industry %

-77.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ COGT Healthcare

$32.31

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

16/25

Volume

3/15

Valuation

10/20

TP/AR

2/10

Options

8/10

RSI

39.8

Range 1M

29.3%

Sup Dist

5.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

14/30

Estimates

0/20

Inst/Vol

7/15

Options

8/10

EPS Yr

-2.5%

EPS NY

53.5%

52W%

63.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +72.8% upside

Quality

2/30

Valuation

12/30

Growth

10/25

Stability

8/10

LT Trend

0/5

Upside

+72.8%

Quality

COGT — P/E HistoricalBiotechnology

Cogent Biosciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 258

Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma; CGT4255, a novel ErbB2 mutant program, which is focused on actionable and underserved mutations in a solid tumor systemic and CNS involved indications; and CGT6297, a Novel PI3Ka mutant-selective inhibitor. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.

COGT

Latest News

—

Caricamento notizie per COGT…

stock quote shares COGT – Cogent Biosciences Inc Stock Price stock today

news today COGT – Cogent Biosciences Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch COGT – Cogent Biosciences Inc yahoo finance google finance

stock history COGT – Cogent Biosciences Inc invest stock market

stock prices COGT premarket after hours

ticker COGT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: COGT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y